Anti-IL-33 (Human) pAb

MBL

Catalog No: MBL-PM033

Browse all MBL products from our MBL products homepage.

Polyclonal Antibody targeting IL-33/ST2 for IHC, WB.

Product Specifications

• Application: WB, IHC
• Reactivity: Human
• Clonality: Polyclonal
• Host: Rabbit
• Immunogen: Full-length recombinant human IL-33 (270 a.a.)
• Gene ID - Human:

  90865

• Formulation: 100 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained.

Citations for Anti-IL-33 (Human) pAb – 7 Found

Matsuda, Akira; Okayama, Yoshimichi; Terai, Noriko; Yokoi, Norihiko; Ebihara, Nobuyuki; Tanioka, Hidetoshi; Kawasaki, Satoshi; Inatomi, Tsutomu; Katoh, Norito; Ueda, Eiichiro; Hamuro, Junji; Murakami, Akira; Kinoshita, Shigeru. The role of interleukin-33 in chronic allergic conjunctivitis. Investigative Ophthalmology & Visual Science. 2009;50(10):4646-52. 
- Comments: Used in: IHC

Nomura, Kazuaki; Kojima, Takashi; Fuchimoto, Jun; Obata, Kazufumi; Keira, Takashi; Himi, Tetsuo; Sawada, Norimasa. Regulation of interleukin-33 and thymic stromal lymphopoietin in human nasal fibroblasts by proinflammatory cytokines. The Laryngoscope. 2012;122(6):1185-92. 
- Comments: Used in: WB

Nomura, Kazuaki; Kojima, Takashi; Fuchimoto, Jun; Obata, Kazufumi; Keira, Takashi; Himi, Tetsuo; Sawada, Norimasa. Regulation of interleukin-33 and thymic stromal lymphopoietin in human nasal fibroblasts by proinflammatory cytokines. The Laryngoscope. 2012;122(6):1185-92. 
- Comments: Used in: ICC

Guo, Zhi; Wu, Jinxiang; Zhao, Jiping; Liu, Fen; Chen, Yingjian; Bi, Liquan; Liu, Shuying; Dong, Liang. IL-33 promotes airway remodeling and is a marker of asthma disease severity. The Journal Of Asthma : Official Journal Of The Association For The Care Of Asthma. 2014;51(8):863-9. 
- Comments: Used in: IHC

Abe, Kazumichi; Takahashi, Atsushi; Fujita, Masashi; Hayashi, Manabu; Okai, Ken; Nozawa, Yoshihiro; Ohira, Hiromasa. Interleukin-33/ST2-Mediated Inflammation Plays a Critical Role in the Pathogenesis and Severity of Type I Autoimmune Hepatitis. Hepatology Communications. 2019;3(5):670-684. 
- Comments: Used in: IHC

Nagaoka, Satoshi; Yamada, Daisaku; Eguchi, Hidetoshi; Yokota, Yuki; Iwagami, Yoshifumi; Asaoka, Tadafumi; Noda, Takehiro; Kawamoto, Koichi; Gotoh, Kunihito; Kobayashi, Shogo; Miyoshi, Eiji; Doki, Yuichiro; Mori, Masaki. The blockade of interleukin-33 released by hepatectomy would be a promising treatment option for cholangiocarcinoma. Cancer Science. 2021;112(1):347-358. 
- Comments: Used in: IHC

Nagaoka, Satoshi; Yamada, Daisaku; Eguchi, Hidetoshi; Yokota, Yuki; Iwagami, Yoshifumi; Asaoka, Tadafumi; Noda, Takehiro; Kawamoto, Koichi; Gotoh, Kunihito; Kobayashi, Shogo; Miyoshi, Eiji; Doki, Yuichiro; Mori, Masaki. The blockade of interleukin-33 released by hepatectomy would be a promising treatment option for cholangiocarcinoma. Cancer Science. 2021;112(1):347-358. 
- Comments: Used in: IF